2014
DOI: 10.1007/s12288-014-0344-x
|View full text |Cite
|
Sign up to set email alerts
|

Pityriasis Lichenoids Chronica as a Paraneoplastic Dermatosis for Primary Splenic Diffuse Large B Cell Lymphoma

Abstract: Paraneoplastic dermatosis is defined as both benign skin lesions and internal malignancy existing at the same time with parallel clinical courses. Herein, we report a 91-year-old male who presented as pityriasis lichenoids chronica (PLC) concomitantly with a primary splenic diffuse large B cell lymphoma. Surgical removal of the spleen cleared his skin lesions dramatically. However, seven months later, the splenic lymphoma relapsed in concordance with the recurrence of the skin lesions of PLC. To our knowledge,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…1 More rarely, PLC may be seen as a paraneoplastic phenomenon or a reaction to a medication. 3 , 4 Some researchers label PLC as a lymphoproliferative disorder given that these patients have demonstrated T-cell clonality, but this is highly debated in the literature. 1 , 2 , 5 Herein, we present a case of PLC in a patient with diffuse large B-cell lymphoma (DLBCL) who developed a rash after initiating tafasitamab/lenalidomide therapy.…”
Section: Introductionmentioning
confidence: 99%
“…1 More rarely, PLC may be seen as a paraneoplastic phenomenon or a reaction to a medication. 3 , 4 Some researchers label PLC as a lymphoproliferative disorder given that these patients have demonstrated T-cell clonality, but this is highly debated in the literature. 1 , 2 , 5 Herein, we present a case of PLC in a patient with diffuse large B-cell lymphoma (DLBCL) who developed a rash after initiating tafasitamab/lenalidomide therapy.…”
Section: Introductionmentioning
confidence: 99%